ArticleBritish journal of pharmacology2019

Salinomycin exerts anti-colorectal cancer activity by targeting the β-catenin/T-cell factor complex.

Zhongyuan Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.